10 Year Financial Data of Albany Molecular Research, Inc. (AMRI)

12.01 (1y: +352%)

Market Cap	380.16 M	P/E(ttm)	56.20
Enterprise Value	359.63 M	P/B	1.90

AMRI- NAS (USA)
Albany Molecular Research, Inc.

Currently 1/5

Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$12.01

1 Severe Warning Sign 4 Medium Warning Signs 1 Good Sign

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	3	1.6	10.8
EBITDA Growth (%)	0	0	0
Free Cash Flow Growth (%)	0	0	0
Book Value Growth (%)	-3.5	-3.5	0

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	6.04	5.37	5.63	5.77	5.82	7.25	6.32	6.46	6.93	7.48	7.62	1.78	1.65	1.84	2.24	1.89
EBITDA per Share	1.84	0.22	1.20	0.47	0.86	1.39	-0.16	-1.80	-0.61	0.59	0.94	0.09	0.19	0.10	0.22	0.43
Free Cashflow per Share	0.48	0.41	0.73	-0.16	0.41	0.07	0.75	-0.46	-0.43	0.16	0.58	-0.26	0.10	0.06	0.27	0.15
Earnings per Share ($)	0.96	-0.37	0.50	0.07	0.27	0.65	-0.54	-2.05	-1.08	-0.12	0.21	-0.13	0.01	-0.07	0.06	0.21
Book Value per Share	9.30	9.35	9.59	10.21	10.11	10.33	10.13	7.95	6.89	6.80	6.81	6.81	6.77	6.76	6.86	6.81
Month End Stock Price	15.01	11.14	12.15	10.56	14.38	9.74	9.08	5.62	2.93	5.28	10.51	2.70	2.55	3.47	5.28	10.51
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	10.30	-4.00	5.20	0.70	2.70	6.30	-5.30	-25.80	-15.60	-1.80	12.00	-7.60	0.40	-4.00	3.60	12.00
Return on Assets %	7.90	-3.10	4.30	0.60	2.30	5.30	-4.50	-19.30	-12.30	-1.40	9.60	-5.60	0.40	-3.20	2.80	9.60
Return on Capital - Joel Greenblatt %	23.30	-4.50	12.60	-0.40	5.70	11.70	-10.60	-35.60	-18.50	0.40	19.60	-3.60	3.20	-2.40	4.80	19.60
Debt to Equity	0.19	0.18	0.07	0.06	0.04	0.04	0.04	0.05	0.03	0.04	0.04	0.03	0.04	0.04	0.04	0.04

Gross Margin %	48.20	42.80	38.80	28.50	31.40	36.30	29.40	22.90	18.90	25.90	36.30	26.10	27.50	21.70	27.90	36.30
Operating Margin %	23.70	-5.20	12.80	-0.50	5.90	11.30	-11.10	-36.40	-17.40	0.30	15.80	-3.60	3.00	-2.00	3.40	15.80
Net Margin %	15.90	-6.90	8.90	1.20	4.60	9.00	-8.50	-31.70	-15.60	-1.70	11.00	-7.10	0.50	-3.80	2.90	11.00

Days Sales Outstanding	58.50	57.00	56.50	83.20	65.10	72.00	57.10	88.10	71.50	81.60	75.60	80.50	83.40	72.50	68.60	75.60
Days Inventory	123	122	99.20	64.30	62.40	71.60	66.10	64.80	56.30	61.30	78.80	67.20	90.10	69.10	53.00	78.80
Inventory Turnover	3.00	3.00	3.70	5.70	5.80	5.10	5.50	5.60	6.50	6.00	1.20	1.40	1.00	1.30	1.70	1.20

Debt to Revenue	0.29	0.31	0.13	0.10	0.07	0.06	0.07	0.07	0.03	0.04	0.14	0.10	0.16	0.14	0.12	0.14
COGS to Revenue	0.52	0.57	0.61	0.72	0.69	0.64	0.71	0.77	0.81	0.74	0.64	0.74	0.72	0.78	0.72	0.64
Inventory to Revenue	0.18	0.19	0.17	0.13	0.12	0.13	0.13	0.14	0.13	0.12	0.55	0.55	0.72	0.60	0.42	0.55
Interest Exp. to Revenue %	0.57	0.19	0.97	1.66	1.66	0.51	0.19	0.14	-0.28	-0.20	-0.14	-0.26	-0.23	-0.20	-0.13	-0.14

Asset Turnover	0.50	0.45	0.49	0.48	0.50	0.59	0.53	0.61	0.79	0.86	0.22	0.20	0.19	0.21	0.26	0.22
Buyback Ratio	-3.60	15.80	-8.10	-26.60	-16.10	-6.30	--	--	--	--	-1.50	--	--	--	--	-1.50
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	196	170	184	180	193	229	196	198	208	227	232	53.70	50.01	55.77	67.21	59.41
Cost of Goods Sold	102	96.93	113	129	132	146	139	153	168	168	166	39.67	36.25	43.66	48.48	37.82
Gross Profit	94.60	72.60	71.26	51.20	60.48	83.19	57.68	45.39	39.18	58.62	66.18	14.03	13.76	12.11	18.73	21.58

Selling, General, &Admin. Expense	25.50	27.60	31.19	34.68	36.03	42.26	41.79	55.68	44.76	44.05	43.77	10.95	10.59	11.40	11.11	10.66
Research &Development	22.47	23.89	14.47	11.43	12.82	13.13	14.55	11.09	7.94	0.91	0.64	0.37	0.23	0.20	0.11	0.11
Earnings Before DDA	59.73	6.90	39.06	14.65	28.34	43.98	-5.06	-55.06	-18.16	18.04	28.97	2.59	5.86	3.06	6.53	13.52

Depreciation, Depletion and Amortization	13.11	15.71	15.52	15.55	16.99	18.02	16.82	17.10	17.97	17.33	16.91	4.54	4.37	4.16	4.27	4.12

Operating Income	46.63	-8.81	23.54	-0.90	11.35	25.96	-21.88	-72.16	-36.13	0.70	12.05	-1.95	1.49	-1.10	2.25	9.40
Interest Income/Expense	1.11	0.32	1.79	2.99	3.19	1.17	0.38	0.28	-0.58	-0.45	-0.39	-0.14	-0.11	-0.11	-0.09	-0.08
Net Income	31.19	-11.69	16.32	2.18	8.94	20.56	-16.70	-62.87	-32.30	-3.78	6.54	-3.81	0.26	-2.14	1.92	6.51

Earnings per Share ($)	0.96	-0.37	0.50	0.07	0.27	0.65	-0.54	-2.05	-1.08	-0.12	0.21	-0.13	0.01	-0.07	0.06	0.21
Total Shares Outstanding	32.49	31.60	32.64	31.19	33.10	31.61	31.06	30.66	29.96	30.32	31.36	30.14	30.27	30.27	30.03	31.36
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	125	134	128	107	108	87.47	111	41.48	20.20	23.29	28.54	8.24	13.40	15.67	23.29	28.54
Accounts Receivable	31.48	26.46	28.49	40.97	34.35	45.20	30.72	47.82	40.66	50.68	49.32	47.49	45.82	44.44	50.68	49.32
Inventory	34.29	32.42	30.60	22.64	22.58	28.67	25.14	27.10	26.00	28.22	32.76	29.31	35.88	33.16	28.22	32.76
Other Current Assets	5.12	9.52	11.77	11.84	10.63	13.18	13.55	17.64	13.70	11.24	13.96	20.90	14.17	14.12	11.24	13.96
Total Current Assets	196	202	199	183	175	175	180	134	101	113	125	106	109	107	113	125

Property, Plant and Equipment	147	146	151	153	158	168	167	163	150	136	133	145	142	141	136	133
Intangible Assets	46.92	26.95	27.18	37.91	48.81	42.29	20.01	20.64	2.98	3.07	3.08	2.99	3.06	3.12	3.07	3.08
Other Long Term Assets	3.55	2.05	2.16	1.76	4.56	6.38	6.47	7.21	9.74	10.85	9.47	9.38	12.87	12.47	10.85	9.47
Total Assets	393	377	379	375	387	391	374	325	263	263	270	263	267	264	263	270

Accounts Payable	8.78	14.92	15.39	18.43	17.76	23.06	19.69	29.28	24.59	24.71	24.98	26.52	28.85	27.29	24.71	24.98
Current Portion of Long-Term Debt	4.52	4.53	4.54	4.54	9.90	0.26	0.27	1.48	2.84	0.78	0.95	2.44	0.42	0.60	0.78	0.95
Other Current Liabilities	8.63	2.94	20.00	9.72	8.71	10.50	10.78	23.88	10.55	10.50	10.62	11.07	10.57	10.26	10.50	10.62
Total Current Liabilities	21.93	22.38	39.93	32.69	36.37	33.82	30.73	54.64	37.98	35.99	36.56	40.03	39.84	38.15	35.99	36.56

Long-Term Debt	53.13	48.60	18.52	13.99	4.08	13.48	13.21	11.74	3.00	7.23	7.05	3.00	7.59	7.41	7.23	7.05
Other Long-Term Liabilities	15.29	10.43	7.67	10.36	11.64	16.70	15.13	14.99	15.65	13.51	12.82	14.99	14.95	14.35	13.51	12.82
Total Liabilities	90.35	81.42	66.12	57.04	52.09	64.00	59.08	81.36	56.63	56.72	56.42	58.02	62.38	59.91	56.72	56.42

Common Stock	0.34	0.34	0.35	0.35	0.35	0.35	0.36	0.36	0.36	0.36	0.37	0.36	0.36	0.36	0.36	0.37
Retained Earnings	155	143	159	161	170	191	174	111	78.95	75.18	81.68	75.15	75.40	73.26	75.18	81.68
Additional Paid-In Capital	184	190	193	196	196	199	202	204	206	208	209	207	207	208	208	209
Treasury Stock	-37.17	-37.17	-37.17	-37.17	-37.17	-56.89	-56.89	-66.89	-66.89	-66.89	-66.89	-66.89	-66.89	-66.89	-66.89	-66.89
Total Equity	302	295	313	318	335	327	315	244	206	206	214	205	205	205	206	214
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	31.19	-11.69	16.32	2.18	8.94	20.56	-16.70	-62.87	--	-3.78	4.20	--	--	--	-2.31	6.51
Depreciation, Depletion and Amortization	13.11	15.71	15.52	15.55	16.99	18.02	16.82	17.10	17.97	17.33	16.91	4.54	4.37	4.16	4.27	4.12
Cash Flow from Others	2.00	32.55	11.01	-6.41	5.74	-12.04	38.96	44.45	-19.45	1.78	7.04	-10.22	1.21	0.37	8.95	-3.49
Cash Flow from Operations	46.29	36.57	42.85	11.32	31.67	26.54	39.09	-1.32	-1.48	15.34	28.15	-5.68	5.57	4.53	10.91	7.13

Investment for Property, Plant & Equipement	-30.55	-23.72	-19.17	-16.45	-18.26	-24.36	-15.87	-12.65	-11.26	-10.44	-10.72	-2.29	-2.43	-2.86	-2.87	-2.56
Cash Flow from Acquisitions	-28.30	--	--	-11.61	-11.90	-1.73	-0.01	-46.34	--	--	--	--	--	--	--	--
Cash Flow from Investing	-42.45	-10.91	-27.60	-9.05	-9.79	8.98	-19.09	-45.06	3.97	-9.78	-10.32	-2.02	-2.43	-2.46	-2.87	-2.56

Net Issuance of Stock	-12.36	1.85	1.32	0.58	1.44	-18.43	--	-10.00	--	--	0.40	0.23	0.11	0.19	-0.53	0.63
Net Issuance of Debt	21.11	-4.52	-30.07	-4.59	-4.55	-0.24	-0.26	-0.27	-7.37	-3.07	1.69	-4.91	2.07	-0.00	-0.23	-0.15
Other Financing	-0.00	--	0.00	0.00	0.12	0.06	0.52	0.59	0.40	0.53	0.88	-0.00	0.00	--	0.53	0.35
Cash Flow from Financing	8.75	-2.68	-28.75	-4.00	-3.00	-18.61	0.26	-9.68	-6.97	-2.53	2.97	-4.67	2.18	0.19	-0.23	0.83

Net Change in Cash	12.60	22.98	-13.57	-1.48	19.38	14.89	20.55	-55.21	-5.76	3.31	20.29	-11.74	5.15	2.28	7.62	5.24

Free Cash Flow	15.74	12.85	23.68	-5.14	13.40	2.18	23.22	-13.97	-12.74	4.90	17.43	-7.97	3.15	1.67	8.04	4.57
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

AMRI Quarterly/Annuals Reports

AMRI: 10-Q - ALBANY MOLECULAR RESEARCH INC (0001065087) (Filer): (10-Q) - 2012-11-09
AMRI: 10-Q/A - ALBANY MOLECULAR RESEARCH INC (0001065087) (Filer): (10-Q/A) - 2012-08-20
AMRI: 10-Q - ALBANY MOLECULAR RESEARCH INC (0001065087) (Filer): (10-Q) - 2012-08-09
AMRI: 10-Q - ALBANY MOLECULAR RESEARCH INC (0001065087) (Filer): (10-Q) - 2012-05-10
AMRI: 10-K - ALBANY MOLECULAR RESEARCH INC (0001065087) (Filer): (10-K) - 2012-03-15

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

AMRI Quarterly/Annuals Reports